These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34013111)

  • 1. Rare Collagenous Heterozygote Variants in Children With IgA Nephropathy.
    Cambier A; Robert T; Hogan J; Rabant M; Peuchmaur M; Boyer O; Ulinski T; Monteiro RC; Mesnard L
    Kidney Int Rep; 2021 May; 6(5):1326-1335. PubMed ID: 34013111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 27 Novel Variants in Genes
    Cerkauskaite A; Savige J; Janonyte K; Jeremiciute I; Miglinas M; Kazenaite E; Laurinavicius A; Strupaite-Sileikiene R; Vainutiene V; Burnyte B; Jankauskiene A; Rolfs A; Bauer P; Schröder S; Cerkauskiene R
    Front Med (Lausanne); 2022; 9():859521. PubMed ID: 35419377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological analysis of IgA nephropathy combined with other glomerular diseases.
    Jiang L; Dong B; Yan Y; Zheng S; Hu Y; Zuo L; Shi H
    Medicine (Baltimore); 2019 Oct; 98(41):e17388. PubMed ID: 31593089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.
    Yuan X; Su Q; Wang H; Shi S; Liu L; Lv J; Wang S; Zhu L; Zhang H
    J Am Soc Nephrol; 2023 Jan; 34(1):132-144. PubMed ID: 36130833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
    Savige J; Harraka P
    Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous Pathogenic
    Savige J
    Kidney Int Rep; 2022 Sep; 7(9):1933-1938. PubMed ID: 36090501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of the Cystic Phenotype in Alport Syndrome.
    Zeni L; Mescia F; Toso D; Dordoni C; Mazza C; Savoldi G; Econimo L; Cortinovis R; Fisogni S; Alberici F; Scolari F; Izzi C
    Am J Kidney Dis; 2024 Sep; 84(3):320-328.e1. PubMed ID: 38514012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
    He JW; Cui DF; Zhou XJ; Chen P; Li Y; Zhang X; Wang YN; Gan T; Liu LJ; Shi SF; Zhu L; Hou P; Lv JC; Zhang H
    Front Immunol; 2022; 13():846323. PubMed ID: 35359934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants.
    Furlano M; Pilco-Teran M; Pybus M; Martínez V; Aza-Carmona M; Rius Peris A; Pérez-Gomez V; Berná G; Mazon J; Hernández J; Fayos de Arizón L; Viera E; Gich I; Pérez HV; Gomá-Garcés E; Albero Dolon JL; Ars E; Torra R
    Nephrol Dial Transplant; 2024 Aug; 39(9):1442-1448. PubMed ID: 38317457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report.
    Bhattacharyya A; Huang Y; Khan SH; Drachenberg CB; Malone LC
    BMC Nephrol; 2021 Oct; 22(1):358. PubMed ID: 34717572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Disease Associated With Mono-allelic
    Groen In 't Woud S; Rood IM; Steenbergen E; Willemsen B; Dijkman HB; van Geel M; Schoots J; Wetzels JFM; Lugtenberg D; Deegens JKJ; Bongers EMHF
    Kidney Med; 2023 Apr; 5(4):100607. PubMed ID: 36925663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
    Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
    Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
    Cambier A; Dossier C; Hogan J; Baudouin V; Maisin A; Couderc A; Kwon T; Gleeson PJ; Monteiro RC
    Pediatr Nephrol; 2022 Jul; 37(7):1597-1603. PubMed ID: 34997322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thin basement membrane nephropathy.
    Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
    Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria.
    Savige J; Storey H; Watson E; Hertz JM; Deltas C; Renieri A; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Lipska-Ziętkiewicz BS
    Eur J Hum Genet; 2021 Aug; 29(8):1186-1197. PubMed ID: 33854215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-Phenotype Correlations for Pathogenic
    Savige J; Huang M; Croos Dabrera MS; Shukla K; Gibson J
    Front Med (Lausanne); 2022; 9():865034. PubMed ID: 35602506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
    Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3/COL4A4?
    Riedhammer KM; Simmendinger H; Tasic V; Putnik J; Abazi-Emini N; Stajic N; Berutti R; Weidenbusch M; Patzer L; Lungu A; Milosevski-Lomic G; Günthner R; Braunisch MC; Ćomić J; Hoefele J
    Clin Genet; 2024 Apr; 105(4):406-414. PubMed ID: 38214412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.